Cargando…
Evaluation of Cellular Fibronectin Plasma Levels as a Useful Staging Tool in Different Stages of Transitional Cell Carcinoma of the Bladder and Renal Cell Carcinoma
Reliable markers for both renal cell carcinoma (RCC) and transitional cell carcinoma of the bladder (TCC) are lacking. During tumor progression and invasion components of extracellular matrix (ECM) are degraded and parts of these different components are detectable in plasma. Cellular fibronectin (c...
Autores principales: | Hegele, A., Hofmann, R., Kosche, B., Kropf, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717843/ https://www.ncbi.nlm.nih.gov/pubmed/19662188 |
Ejemplares similares
-
Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour
por: Kondisetty, Sandeep, et al.
Publicado: (2018) -
Sex-related differences in urothelial cell carcinoma of the bladder in Germany
por: Scheller, Thomas, et al.
Publicado: (2018) -
Serum fibronectin distinguishes the early stages of hepatocellular carcinoma
por: Kim, Hyunsoo, et al.
Publicado: (2017) -
Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
por: Maslov, Dmitry L., et al.
Publicado: (2022) -
Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder
por: Ali-El-Dein, Bedeir, et al.
Publicado: (2011)